Andere Sprachen Implantica AG

Aktien

A2QCUH

SE0014855029

IMP A SDB

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 12:59:57 30.04.2024			% 5 Tage	% 1. Jan.
27.4 ^SEK	+0.37%		-5.35%	+14.64%

27.03.	Implantica reicht erstes Modul des US FDA-Zulassungsantrags für GERD-Medizinprodukt ein	MT
27.03.	Implantica reicht bei der U.S. FDA Antrag auf Premarket Approval (PMA) für RefluxStop® (erstes Modul) ein	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	26.04.
Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	27.03.
Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)	27.03.
Implantica Completes Human Factors Validation Study for RefluxStop as Part of the US FDA Premarket Approval Process	26.03.
Implantica to Deploy GERD Treatment in Spain	19.03.
Implantica AG (publ.) Wins Another RefluxStop Public Tender in Europe with Hospital Universitario De Getafe	19.03.
Implantica AG (OM:IMP A SDB) acquired IRCCS Saverio De Bellis.	05.03.
Implantica AG Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16.02.
Implantica Announces Completion of its First RefluxStop Procedures at Artemed Klinikum München Süd in Munich, Germany	15.02.
Implantica Announces First Refluxstop Public Tender Win, Paving the Way for Permanent Reimbursement in Italy	13.02.
Implantica Ag Announces the First RefluxStop Procedures Completed At MIC Hospital in Berlin	06.02.
Implantica AG (publ.) Adds Another RefluxStop Center in Spain	18.12.
Implantica AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22.11.
Implantica AG (publ.)'s RefluxStop Offers for the First Time in the NHS in UK	21.11.
Implantica Wins EU Medical Device Certifications	07.09.23
Implantica AG Receives MDR Certification for RefluxStop?	07.09.23
Implantica AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24.08.23
Implantica AG Further Expands Its Commercial Footprint in Italy	29.06.23
Implantica AG Announces RefluxStop Results Were Presented At the DDW Conference in Chicago	16.05.23
Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	12.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Implantica AG

Aktien

A2QCUH

SE0014855029

IMP A SDB

Andere Sprachen

Filter